Dr. Daniel Lawrence Wolfson, MD

Dr. Wolfson practices at Baptist Health Primary Care - HOPD in Miami Beach, Florida.

Dr. Wolfson's NPI, 1124230958, was assigned on May 4, 2007. Dr. Wolfson graduated from SUNY Downstate Health Sciences University in 2001. Dr. Wolfson holds Florida license ME0098505.

Dr. Wolfson's primary practice is Baptist Health Primary Care - HOPD, at 709 Alton Rd, STE 300, Miami Beach, FL 33139.

Dr. Wolfson's primary practice is Baptist Health Primary Care - HOPD in Miami Beach, Florida. Dr. Wolfson is also affiliated with Mount Sinai Medical Center. The medical group on file is Physicians Group of South Florida. Dmand AI also links Dr. Wolfson to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wolfson practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Wolfson's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Wolfson is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Wolfson is licensed in Florida.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), colonoscopy, gastroduodenitis, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Wolfson treats.

CMS data shows 2,106 Medicare services from Dr. Wolfson across 12 procedure codes in 2024, for 504 Medicare patients. Medicare paid $128,764 for them.

CMS counts 504 Medicare patients who saw Dr. Wolfson in 2024. The largest group is 65 to 74, with 206 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wolfson's median patient age at 56, with 47% women.

In 2024, Dr. Wolfson wrote 284 Medicare Part D claims for 94 patients. 90% of them were for generic drugs. CMS names the drug for 166 of them, across 5 drugs with 11 or more claims each, at $14,264 in total drug cost. In 2023, CMS named 194 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Wolfson for performance year 2024, reported individually. Dr. Wolfson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wolfson as offering telehealth. CMS counts 132 procedures of colonoscopy by Dr. Wolfson, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Wolfson in 2017. Dr. Wolfson's most frequent co-authors are Binna Manojkumar Chokshi, MD, Vivek Ketan Choksi, MD and Andrew Chu, MD.

CMS Open Payments shows 187 general payments to Dr. Wolfson from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Abbvie Inc. paid the most, $1,603.

Dmand AI lists 1 award for Dr. Wolfson, most recently CMS Stage 1 EHR in 2012.

Dr. Wolfson graduated from SUNY Downstate Health Sciences University in 2001.

Dr. Wolfson is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.